Rebastinib, a selective TIE2 kinase inhibitor, decreases TIE2-expressing macrophages, reduces metastasis, and increases survival in murine cancer models

被引：0
|
作者：
Flynn, Daniel L. [1 ]
Kaufman, Michael D. [1 ]
Leary, Cynthia B. [1 ]
Hood, Molly M. [1 ]
Lu, Wei-Ping [1 ]
Turner, Benjamin A. [1 ]
Wise, Scott C. [1 ]
Rudoltz, Marc S. [1 ]
Smith, Bryan D. [1 ]
机构：
[1] Deciphera Pharmaceut LLC, Lawrence, KS USA
来源：
CANCER RESEARCH | 2015年 / 75卷 / 01期
关键词：
D O I：
10.1158/1538-7445.CHTME14-PR01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR01
引用
收藏
页数：1
相关论文
共 13 条
  • [1] Rebastinib in combination with paclitaxel ablates TIE2-expressing macrophages, reduces metastasis, and increases survival in the PyMT metastatic breast cancer model
    Smith, B. D.
    Leary, C. B.
    Kaufman, M. D.
    Hood, M. M.
    Lu, W-P
    Turner, B. A.
    Vogeti, S.
    Wise, S. C.
    Berger, M. S.
    Flynn, D. L.
    CANCER RESEARCH, 2013, 73
  • [2] Rebastinib in combination with eribulin ablates TIE2-expressing macrophages, reduces metastasis, and increases survival in the PyMT metastatic breast cancer model
    Smith, B. D.
    Leary, C. B.
    Kaufman, M. D.
    Hood, M. M.
    Lu, W-P
    Turner, B. A.
    Vogeti, S.
    Wise, S. C.
    Berger, M. S.
    Flynn, D. L.
    CANCER RESEARCH, 2013, 73
  • [3] The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
    Harney, Allison S.
    Karagiannis, George S.
    Pignatelli, Jeanine
    Smith, Bryan D.
    Kadioglu, Ece
    Wise, Scott C.
    Hood, Molly M.
    Kaufman, Michael D.
    Leary, Cynthia B.
    Lu, Wei-Ping
    Al-Ani, Gada
    Chen, Xiaoming
    Entenberg, David
    Oktay, Maja H.
    Wang, Yarong
    Chun, Lawrence
    De Palma, Michele
    Jones, Joan G.
    Flynn, Daniel L.
    Condeelis, John S.
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (11) : 2486 - 2501
  • [4] The Tie2 antagonist rebastinib reduces ovarian cancer growth in a syngeneic murine model
    Gupta, Vijayalaxmi G.
    Roby, Katherine F.
    Pathak, Harsh B.
    Godwin, Andrew K.
    Gunewardena, Sumedha
    Khabele, Dineo
    BMC CANCER, 2025, 25 (01)
  • [5] Rebastinib potently inhibits function of perivascular TIE2 expressing macrophages in vitro and in vivo
    Harney, Allison
    Pignatelli, Jeanine
    Leung, Edison
    Oktay, Maja
    Wang, Yarong
    Smith, Bryan D.
    Flynn, Daniel L.
    Condeelis, John S.
    CANCER RESEARCH, 2015, 75
  • [6] Rebastinib, a small molecule TIE2 kinase inhibitor, prevents primary tumor growth and lung metastasis in the PyMT breast cancer model
    Smith, Bryan D.
    Hood, Molly M.
    Kaufman, Michael D.
    Berger, Mark
    Flynn, Daniel L.
    Wise, Scott C.
    CANCER RESEARCH, 2013, 73
  • [7] Rebastinib, a TIE2 antagonist improves chemotherapy response in homologous recombination proficient epithelial ovarian cancer murine models
    Gupta, Vijayalaxmi G.
    Roby, Katherine F.
    Pathak, Harsh B.
    Godwin, Andrew K.
    Gunewardena, Sumedha
    Khabele, Dineo
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages
    Ehrentraut, Heidi
    Weisheit, Christina
    Scheck, Marcel
    Frede, Stilla
    Hilbert, Tobias
    JOURNAL OF INFLAMMATION-LONDON, 2018, 15
  • [9] Experimental murine acute lung injury induces increase of pulmonary TIE2-expressing macrophages
    Heidi Ehrentraut
    Christina Weisheit
    Marcel Scheck
    Stilla Frede
    Tobias Hilbert
    Journal of Inflammation, 15
  • [10] Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer
    Anampa, Jesus D.
    Flynn, Daniel L.
    Leary, Cynthia
    Oh, Sun
    Xue, Xiaonan
    Oktay, Maja H.
    Condeelis, John S.
    Sparano, Joseph A.
    CLINICAL CANCER RESEARCH, 2025, 31 (02) : 266 - 277
12